Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report.
Am J Perinatol
; 15(5): 295-7, 1998 May.
Article
in En
| MEDLINE
| ID: mdl-9643634
ABSTRACT
Chemotherapeutic agents administered to the mother during pregnancy may severely jeopardize the fetus. We describe a newborn girl who had been exposed to idarubicin and cytosine-arabinoside during the second and third trimesters of pregnancy due to treatment of newly diagnosed acute myeloid leukemia in the mother. The child had no structural congenital abnormalities. Adverse effects observed were prematurity, growth retardation, mildly disturbed transaminases and erythroblastosis, all of which were self-limiting with no permanent sequelae.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pregnancy Complications, Neoplastic
/
Prenatal Exposure Delayed Effects
/
Antineoplastic Combined Chemotherapy Protocols
/
Leukemia, Monocytic, Acute
/
Fetal Growth Retardation
Limits:
Female
/
Humans
/
Newborn
/
Pregnancy
Language:
En
Journal:
Am J Perinatol
Year:
1998
Document type:
Article
Affiliation country: